Related Experiment Video
Updated: Aug 17, 2026

Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
Published on: June 7, 2019
Bone morphogenetic proteins in melanoma: angel or devil?
Mei-Yu Hsu1, Sherry Rovinsky, Sunita Penmatcha
1Department of Pathology, University of Iowa Carver College of Medicine, Iowa City, IA, 52242, USA. mei-yu-hsu@uiowa.edu
Abstract:
Bone morphogenetic proteins (BMPs) are members of the transforming growth factor-beta (TGF-beta) superfamily serving multiple functions in many cell and tissue types including proliferation, apoptosis, differentiation, chemotaxis, angiogenesis, and matrix production during embryogenic development as well as in adult life. Despite the tremendous progress in delineating functional derangements of BMP pathways in carcinogenesis during the last decade, the biological significance of BMPs in human melanoma has received very little attention. It is now clear that biological responses to BMPs are cell type-specific and divergent effects, i.e., both oncogenic and tumor suppressor activities, have been described. Thus, knowledge generated in one system may not translate directly to another. In this review, we summarize the current understanding of BMP signaling in various human cancers and discuss original data pertaining to cutaneous melanoma obtained in our laboratory.
More Related Videos
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
TGF - β Signaling Pathway
Determination
Bone Remodeling
Bone Remodeling and Repair
Mitogens and the Cell Cycle

